NEW YORK (GenomeWeb News) – Cellectis Bioresearch today announced a collaboration with Axxam to offer integrated discovery services based on genomic engineering technologies.

According to Cellectis, a genome engineering firm, the collaboration will offer a one-stop shop approach to generating cell-based assays to the life science industry. Cellectis will use its genome engineering methods to modify genes of interest, and then Axxam will apply its expertise and technologies for cell line generation to develop functional cellular assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.